0000899243-21-002235.txt : 20210115
0000899243-21-002235.hdr.sgml : 20210115
20210115200009
ACCESSION NUMBER: 0000899243-21-002235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: George Adam D.
CENTRAL INDEX KEY: 0001754239
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 21533514
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB24 9BZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-13
1
0001351288
GW PHARMACEUTICALS PLC
GWPH
0001754239
George Adam D.
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
0
1
0
0
Secretary
Ordinary Shares
2021-01-13
4
M
0
3636
0.0014
A
13636
D
Ordinary Shares
2021-01-13
4
M
0
97008
0.0014
A
110644
D
Ordinary Shares
2021-01-13
4
M
0
67704
3.72
A
178348
D
Ordinary Shares
2021-01-13
4
M
0
99180
0.0014
A
277528
D
Ordinary Shares
2021-01-13
4
M
0
132984
0.0014
A
410512
D
Ordinary Shares
2021-01-13
4
M
0
78336
0.0014
A
488848
D
Ordinary Shares
2021-01-13
4
M
0
5868
0.0014
A
494716
D
Ordinary Shares
2021-01-13
4
M
0
5868
0.0014
A
500584
D
Ordinary Shares
2021-01-13
4
M
0
5868
0.0014
A
506452
D
Ordinary Shares
2021-01-13
4
M
0
5868
0.0014
A
512320
D
Ordinary Shares
2021-01-13
4
M
0
96336
0.0014
A
608656
D
Ordinary Shares
2021-01-13
4
M
0
77088
0.0014
A
685744
D
Ordinary Shares
2021-01-13
4
S
0
181488
10.91
D
504256
D
Ordinary Shares
2021-01-13
4
S
0
145200
11.00
D
359056
D
Ordinary Shares
2021-01-13
4
S
0
222552
11.08
D
136504
D
Ordinary Shares
2021-01-13
4
S
0
121764
11.15
D
14740
D
Ordinary Shares
2021-01-13
4
S
0
4740
11.23
D
10000
D
Share Options
0.0014
2021-01-13
4
M
0
3636
0.00
D
2019-06-24
2025-06-24
Ordinary Shares
3636
0
D
Share Options
0.0014
2021-01-13
4
M
0
97008
0.00
D
2026-02-15
Ordinary Shares
97008
10
D
Share Options
3.72
2021-01-13
4
M
0
67704
0.00
D
2019-02-15
2026-02-15
Ordinary Shares
67704
3
D
Share Options
0.0014
2021-01-13
4
M
0
99180
0.00
D
2027-01-06
Ordinary Shares
99180
0
D
Share Options
0.0014
2021-01-13
4
M
0
132984
0.00
D
2028-02-26
Ordinary Shares
132984
0
D
Share Options
0.0014
2021-01-13
4
M
0
78336
0.00
D
2020-12-31
2029-03-01
Ordinary Shares
78336
0
D
Share Options
0.0014
2021-01-13
4
M
0
5868
0.00
D
2020-03-01
2029-03-01
Ordinary Shares
5868
0
D
Share Options
0.0014
2021-01-13
4
M
0
5868
0.00
D
2020-12-31
2029-03-01
Ordinary Shares
5868
0
D
Share Options
0.0014
2021-01-13
4
M
0
5868
0.00
D
2020-12-31
2029-03-01
Ordinary Shares
5868
0
D
Share Options
0.0014
2021-01-13
4
M
0
5868
0.00
D
2020-12-31
2029-03-01
Ordinary Shares
5868
0
D
Share Options
0.0014
2021-01-13
4
M
0
96336
0.00
D
2020-12-31
2030-06-04
Ordinary Shares
96336
32112
D
Share Options
0.0014
2021-01-13
4
M
0
77088
0.00
D
2020-12-31
2030-06-04
Ordinary Shares
77088
0
D
Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares of ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.36 U.S. Dollars as of January 13, 2020.
The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
Represented by ADSs.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($130.9153 per ADS). These shares were sold in multiple transactions at prices ranging from $130.48 per ADS (or $10.87 per ordinary share) to $131.44 per ADS (or $10.95 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.0454 per ADS). These shares were sold in multiple transactions at prices ranging from $130.48 per ADS (or $10.87 per ordinary share) to $132.48 per ADS (or $11.04 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.9121 per ADS). These shares were sold in multiple transactions at prices ranging from $132.50 per ADS (or $11.04 per ordinary share) to $133.48 per ADS (or $11.12 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($133.7875 per ADS). These shares were sold in multiple transactions at prices ranging from $133.50 per ADS (or $11.13 per ordinary share) to $134.48 per ADS (or $11.21 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($134.7871 per ADS). These shares were sold in multiple transactions at prices ranging from $134.54 per ADS (or $11.21 per ordinary share) to $134.97 per ADS (or $11.25 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
9,624 shares vested on February 15, 2020. The remaining vested on February 15, 2019.
6,468 shares vested on December 31, 2020 (accelerated due to retirement of the reporting person.) The remaining vested on January 6, 2020.
7,680 shares vested on February 26, 2019; 7,668 shares vested on February 26, 2020; the remained vested on December 31, 2020 (accelerated due to retirement of the reporting person.)
Accelerated due to retirement of the reporting person.
Effective December 31, 2020, the Reporting Person is no longer an officer of the Issuer.
/s/ Adam D. George
2021-01-15